INIS
evaluation
100%
in vitro
100%
in vivo
100%
alkaloids
100%
survival time
100%
doses
83%
animals
50%
control
33%
mice
33%
tumors
33%
effective doses
33%
weight
16%
toxicity
16%
diseases
16%
administration
16%
carcinomas
16%
humans
16%
elevation
16%
concentration
16%
hela cells
16%
death
16%
ascites
16%
cyclophosphamide
16%
time dependence
16%
inoculation
16%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
100%
Alstonia scholaris
100%
Dose
75%
Time
50%
Animal
37%
Survival Time
37%
Median Survival Time
37%
Mouse
25%
Body Weight
12%
IC50
12%
Low Drug Dose
12%
Cyclophosphamide
12%
Inoculation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alkaloid
100%
Alstonia scholaris
100%
Animal
37%
Survival Time
37%
Median Survival Time
37%
Mouse
25%
Neoplasm
25%
Sodium Chloride
12%
Diseases
12%
Anticarcinogen
12%
Death
12%
Ehrlich Ascites Tumor
12%
Deterioration
12%
Cyclophosphamide
12%
Remission
12%
Medicine and Dentistry
Median Survival Time
37%
HL60
25%
Veterinary Science and Veterinary Medicine